HSBC Holdings’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $415K | Buy |
43,966
+25,338
| +136% | +$227K | ﹤0.01% | 2370 |
|
|
2026
Q1 | $149K | Sell |
18,628
-40,153
| -68% | -$364K | ﹤0.01% | 2683 |
|
|
2025
Q4 | $394K | Buy |
+58,781
| New | +$443K | ﹤0.01% | 2413 |
|
|
2025
Q2 | – | Sell |
-17,814
| Closed | -$115K | – | 3172 |
|
|
2025
Q1 | $115K | Sell |
17,814
-117
| -0.7% | -$967 | ﹤0.01% | 2775 |
|
|
2024
Q4 | $144K | Buy |
17,931
+7,344
| +69% | +$70.8K | ﹤0.01% | 2809 |
|
|
2024
Q3 | $137K | Sell |
10,587
-12,678
| -54% | -$164K | ﹤0.01% | 2729 |
|
|
2024
Q2 | $296K | Buy |
23,265
+319
| +1% | +$3.21K | ﹤0.01% | 2293 |
|
|
2024
Q1 | $110K | Buy |
22,946
+8,185
| +55% | +$38K | ﹤0.01% | 2828 |
|
|
2023
Q4 | $71.5K | Hold |
14,761
| – | – | ﹤0.01% | 2626 |
|
|
2023
Q3 | $108K | Sell |
14,761
-4,100
| -22% | -$32.8K | ﹤0.01% | 2539 |
|
|
2023
Q2 | $142K | Sell |
18,861
-947
| -5% | -$7.45K | ﹤0.01% | 2387 |
|
|
2023
Q1 | $135K | Sell |
19,808
-1,255
| -6% | -$11.5K | ﹤0.01% | 2465 |
|
|
2022
Q4 | $205K | Sell |
21,063
-16,102
| -43% | -$284K | ﹤0.01% | 2763 |
|
|
2022
Q3 | $693K | Sell |
37,165
-626
| -2% | -$27.1K | ﹤0.01% | 2010 |
|
|
2022
Q2 | $1.97M | Sell |
37,791
-52,681
| -58% | -$2.73M | ﹤0.01% | 1592 |
|
|
2022
Q1 | $6.66M | Sell |
90,472
-919,774
| -91% | -$82M | 0.01% | 1073 |
|
|
2021
Q4 | $148M | Buy |
1,010,246
+983,434
| +3,668% | +$169M | 0.14% | 124 |
|
|
2021
Q3 | $5.59M | Buy |
26,812
+5,825
| +28% | +$1.28M | 0.01% | 1105 |
|
|
2021
Q2 | $4.45M | Buy |
20,987
+16,348
| +352% | +$3M | ﹤0.01% | 1147 |
|
|
2021
Q1 | $835K | Sell |
4,639
-7,325
| -61% | -$1.46M | ﹤0.01% | 1697 |
|
|
2020
Q4 | $1.35M | Buy |
11,964
+9,961
| +497% | +$1.06M | ﹤0.01% | 1512 |
|
|
2020
Q3 | $221K | Sell |
2,003
-4,287
| -68% | -$522K | ﹤0.01% | 2412 |
|
|
2020
Q2 | $524K | Buy |
+6,290
| New | +$241K | ﹤0.01% | 1809 |
|
|
2019
Q2 | – | Sell |
-1,336
| Closed | -$15K | – | 2811 |
|
|
2019
Q1 | $15K | Buy |
+1,336
| New | +$42.2K | ﹤0.01% | 2684 |
|
|
2017
Q1 | – | Sell |
-2,326
| Closed | -$59K | – | 2438 |
|
|
2016
Q4 | $59K | Buy |
+2,326
| New | +$67.8K | ﹤0.01% | 2656 |
|
|
2015
Q3 | – | Sell |
-640
| Closed | -$143K | – | 2094 |
|
|
2015
Q2 | $143K | Buy |
640
+87
| +16% | +$15.3K | ﹤0.01% | 1881 |
|
|
2015
Q1 | $91K | Sell |
553
-76
| -12% | -$12.3K | ﹤0.01% | 1996 |
|
|
2014
Q4 | $75K | Buy |
+629
| New | +$65.7K | ﹤0.01% | 1747 |
|
Other funds holding NVAX
SCM
S
HSBC Holdings's NVAX Position: Q2 2026 in Review
HSBC Holdings increased its Novavax (NVAX) stake by 136% in Q2 2026, buying an estimated $227K and bringing the position to 43,966 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #2370.
HSBC Holdings first reported a position in NVAX in Q4 2014 and has held it in 28 quarters since. The position peaked at $148M in Q4 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- HSBC Holdings held 43,966 shares of Novavax worth $415K as of Q2 2026.
- HSBC Holdings bought 25,338 Novavax shares in Q2 2026, an estimated $227K.
- Novavax made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2370 holding.
- HSBC Holdings first reported a position in Novavax in Q4 2014 and has held it in 28 quarters since.
- HSBC Holdings's Novavax position peaked at $148M in Q4 2021.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.